Phase III Study on the Efficacy and Safety of Epinastine Hydrochloride Dry Syrup in Pediatric Patients with Atopic Dermatitis-Double-Blind Comparative Study of Epinastine Hyderochloride Dry Syrup with Ketotifen Fumarate Dry Syrup-

Epinastine Hydrochloride Dry Syrup

doi:10.2336/nishinihonhifu.66.60

Phase III Study on the Efficacy and Safety of Epinastine Hydrochloride Dry Syrup in Pediatric Patients with Atopic Dermatitis-Double-Blind Comparative Study of Epinastine Hyderochloride Dry Syrup with Ketotifen Fumarate Dry Syrup-

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.66.60 ◽

2004 ◽

Vol 66 (1) ◽

pp. 60-79 ◽

Cited By ~ 3

Author(s):

Epinastine Hydrochloride Dry Syrup

Keyword(s):

Atopic Dermatitis ◽

Comparative Study ◽

Pediatric Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Ketotifen Fumarate ◽

Phase Iii Study

Download Full-text

Efficacy and Safety of Fexofenadine Hydrochloride in Pediatric Patients with Atopic Dermatitis in a Phase III, Randomized, Double-blind, Multi-center Comparative Study

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.68.553 ◽

2006 ◽

Vol 68 (5) ◽

pp. 553-565 ◽

Cited By ~ 4

Author(s):

Hidemi NAKAGAWA ◽

Makoto KAWASHIMA

Keyword(s):

Atopic Dermatitis ◽

Comparative Study ◽

Pediatric Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and Safety of High-concentration TV-02 Ointment in Patients with Psoriasis Vulgaris. A Double-blind, Right-to-left Comparative Study (Phase III Study).

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.64.105 ◽

2002 ◽

Vol 64 (1) ◽

pp. 105-119 ◽

Cited By ~ 3

Author(s):

Keyword(s):

Comparative Study ◽

Psoriasis Vulgaris ◽

Phase Iii ◽

Study Phase ◽

Efficacy And Safety ◽

High Concentration ◽

Double Blind ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Comparison of the Efficacy and Safety Profiles of a Pelubi Sustained Release Tab Versus a Pelubi Tab in Patients with Chronic Back Pain: A Randomized, Double-Blind, Multi-Institution Phase III Study

Journal of Korean Society of Spine Surgery ◽

10.4184/jkss.2016.23.2.92 ◽

2016 ◽

Vol 23 (2) ◽

pp. 84

Author(s):

Ki Taek Kim ◽

Tae Kyun Kim ◽

Ji Woong Choi ◽

Jae Sung Ahn ◽

Young Do Koh ◽

...

Keyword(s):

Back Pain ◽

Sustained Release ◽

Chronic Back Pain ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.897 ◽

2014 ◽

Vol 71 (3) ◽

pp. 484-492 ◽

Cited By ~ 49

Author(s):

D.S. Krupashankar ◽

Sunil Dogra ◽

Mahendra Kura ◽

Abir Saraswat ◽

Leelavathy Budamakuntla ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Advances in Therapy ◽

10.1007/s12325-021-01899-0 ◽

2021 ◽

Author(s):

Lin Cai ◽

Linfeng Li ◽

Hao Cheng ◽

Yangfeng Ding ◽

Zhenshu Biao ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Phase Iii Study

Download Full-text

Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-1098 ◽

2019 ◽

Vol 25 (10) ◽

pp. 3193-3193

Author(s):

Nicholas Thatcher ◽

Jerome H. Goldschmidt ◽

Michael Thomas ◽

Michael Schenker ◽

Zhiying Pan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin: Results of international multicenter randomized double blind phase III study in patients with advanced non-squamous NSCLC.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8057 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8057-8057 ◽

Cited By ~ 6

Author(s):

Olga Filon ◽

Sergey Orlov ◽

Olga Burdaeva ◽

Mikhail V. Kopp ◽

Bogdan Kotiv ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Study ◽

International Multicenter

Download Full-text